Reider Paul 4
4 · Coherus BioSciences, Inc. · Filed Dec 17, 2024
Insider Transaction Report
Form 4
Reider Paul
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2024-12-13$1.61/sh−2,073$3,338→ 89,204 total
Footnotes (2)
- [F1]Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction.
- [F2]Includes 5,000 shares acquired on November 15, 2024 and 5,000 shares acquired on May 15, 2024, each pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan.